These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35740232)

  • 1. Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021).
    Meschiari M; Onorato L; Bacca E; Orlando G; Menozzi M; Franceschini E; Bedini A; Cervo A; Santoro A; Sarti M; Venturelli C; Biagioni E; Coloretti I; Busani S; Girardis M; Lòpez-Lozano JM; Mussini C
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.
    Langford BJ; Soucy JR; Leung V; So M; Kwan ATH; Portnoff JS; Bertagnolio S; Raybardhan S; MacFadden DR; Daneman N
    Clin Microbiol Infect; 2023 Mar; 29(3):302-309. PubMed ID: 36509377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.
    Ntziora F; Giannitsioti E
    J Intensive Med; 2024 Jul; 4(3):269-280. PubMed ID: 39035613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study.
    Tseng YW; Huang CW; Chen CC; Er TK
    J Infect Public Health; 2024 Feb; 17(2):229-235. PubMed ID: 38118294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.
    Haddad N; Zeenny RM; El Halabi C; Abdallah T; El Helou R; Zahreddine NK; Kanj SS; Rizk NA
    J Infect Public Health; 2024 Feb; 17(2):254-262. PubMed ID: 38128409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection.
    Chang HC; Chang CH; Tien KL; Tai CH; Lin LM; Lee TF; Ku SC; Fang CT; Chen YC; Sheng WH
    J Formos Med Assoc; 2024 Jan; 123(1):123-132. PubMed ID: 37451958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis.
    Li W; Yang X; Liu C; Liu X; Shi L; Zeng Y; Xia H; Li J; Zhao M; Yang S; Li X; Hu B; Yang L
    Front Public Health; 2024; 12():1419344. PubMed ID: 39086796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy.
    Mangioni D; Fox V; Chatenoud L; Bolis M; Bottino N; Cariani L; Gentiloni Silverj F; Matinato C; Monti G; Muscatello A; Teri A; Terranova L; Piatti A; Gori A; Grasselli G; Stocchetti N; Alteri C; Bandera A
    Microbiol Spectr; 2023 Mar; 11(2):e0020923. PubMed ID: 36976013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance patterns among critical priority pathogens in an intensive care unit at a tertiary hospital in Egypt: a descriptive analysis comparing pre- and COVID-19 eras.
    Zafer MM; Bassiouny DM; Ghosh S; Bornman C; Hussein AFA
    J Med Microbiol; 2024 Jun; 73(6):. PubMed ID: 38916589
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
    Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
    Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.
    Abubakar U; Al-Anazi M; Alanazi Z; Rodríguez-Baño J
    J Infect Public Health; 2023 Mar; 16(3):320-331. PubMed ID: 36657243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital.
    Metan G; Demir Çuha M; Hazirolan G; Telli Dizman G; Tanriverdi ES; Otlu B; Tas Z; Zarakolu P; Arik Z; Topeli A; Akinci SB; Ünal S; Uzun Ö
    GMS Hyg Infect Control; 2022; 17():Doc15. PubMed ID: 36157382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogens distribution and antimicrobial resistance pattern of blood stream infections in Southern Italian hospital, 2016-2021 surveillance.
    Della Rocca MT; Panetta V; Durante A; Bucci L; Matano A; Annecchiarico A; Greco R
    New Microbiol; 2023 Feb; 46(1):29-36. PubMed ID: 36853815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data.
    Yang X; Li X; Qiu S; Liu C; Chen S; Xia H; Zeng Y; Shi L; Chen J; Zheng J; Yang S; Tian G; Liu G; Yang L
    J Infect; 2024 Jul; 89(1):106183. PubMed ID: 38754635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
    Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
    PeerJ; 2023; 11():e15007. PubMed ID: 37013147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.
    Jeon K; Jeong S; Lee N; Park MJ; Song W; Kim HS; Kim HS; Kim JS
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.